Biotech companies in the future among top 10 drug sellers / winners & losers of the...

07 Oct 2008 - A recent study of the pharmaceuticals industry views Roche/Genentech as the dominant player(s) in the global pharmaceuticals market in the next four years. The projected market shake-up is the result of the patent crisis which currently puts the pipelines of many of the world´s biggest pharmaceutical companies under enormous pressure while also endangering their revenue streams. In their study, strategy consultants from Novumed Life Science Consulting GmbH identified, analysed and compared the 200 blockbuster drugs of the future and revealed Roche/Genentech as well as several "biotech drugs” conquering the top slots. Of the top 10 among the 200 world wide best selling drugs 2007 only four will continue to occupy a top slot in 2012 as a result of the looming patent expirations. According to the Novumed study... [read full story]